降低急性胰腺炎的病死率：基于日本2021版诊疗指南的探讨

doi:10.3969/j.issn.1000-8535.2024.01.002

广州医药 ›› 2024, Vol. 55 ›› Issue (1): 9-17.DOI: 10.3969/j.issn.1000-8535.2024.01.002

降低急性胰腺炎的病死率：基于日本2021版诊疗指南的探讨

李天洋¹, 古维立²

1 华南理工大学医学院（广东广州 510006）
2 华南理工大学附属第二医院,广州市第一人民医院普通外科（广东广州 510180）

收稿日期:2023-10-19 出版日期:2024-01-20 发布日期:2024-01-24
通讯作者: 古维立,E-mail：lili-6423@163.com
作者简介:古维立日本长崎大学医学博士,主任医师,博士生导师,华南理工大学附属第二医院（广州市第一人民医院）肝胆胰外科学科带头人,日本长崎大学客座教授。历任广州市第一人民医院大外科主任、普外科主任。现为广州市医学会加速康复外科分会主任委员、广东省医学会加速康复外科分会副主任委员、广东省医师协会肝胆分会ERAS组组长、广东省医师协会肝胆分会胆道学组副组长、广东省医师协会普通外科分会副主任委员、日本肝胆胰外科学会委员。2015年获首届“羊城好医生”称号。
主要研究方向：肝癌肿瘤干细胞构建肝癌类器官研究,肝纤维化再生机制与小分子药物影响的研究,肝脏移植免疫耐受机制的研究等。主持多项省项部级课题,获得国家发明及实用新型技术专利各1项。近三年以第一或通讯作者发表SCI论文15篇,累计影响因子60.9分。
基金资助:
广州市科技计划项目（202102010027）

Reducing the fatality rate of acute pancreatitis：A discussion based on the 2021 Edition of the Japanese Guidelines for Acute Pancreatitis

LI Tianyang¹, GU Weili²

1 School of Medicine,South China University of Technology,Guangzhou 510006,China
2 Department of General Surgery,the Second Affiliated Hospital of South China University of Technology,Guangzhou First People's Hospital,Guangzhou 510180,China

Received:2023-10-19 Online:2024-01-20 Published:2024-01-24

摘要/Abstract

摘要： 如何降低急性胰腺炎的病死率是一项意义重大的课题。日本2021版诊疗指南提出了对急性胰腺炎患者的“集束化管理措施”,在此指导下,日本急性胰腺炎总体病死率下降至2.6%,重症急性胰腺炎病死率下降至6.1%,远低于全球各国报道的病死率。本文对该指南之诊疗方案进行分析,并与我国现行指南进行对比,以期对AP患者的临床诊治提供指导意义,并期待日后有更多更深入的该领域相关研究。

关键词: 普通外科, 急性胰腺炎, 病死率, 诊疗方案

Abstract: It is a significant problem that how to reduce the mortality rate of acute pancreatitis．However,under the guidance of the Pancreatitis Bundles from the 2021 Edition of the Japanese Guidelines for Acute Pancreatitis of patients with acute pancreatitis,the overall fatality rate of acute pancreatitis in Japan has decreased to 2.6%,and the fatality rate of severe acute pancreatitis has decreased to 6.1%,which is much lower than the fatality rate reported around the world．We analyze the diagnosis and treatment methods of this guideline and compare it with the current guideline in China,in order to have more relevant studies in the future．

Key words: general surgery, acute pancreatitis, fatality rate, diagnosis and treatment options

李天洋, 古维立. 降低急性胰腺炎的病死率：基于日本2021版诊疗指南的探讨[J]. 广州医药, 2024, 55(1): 9-17.

LI Tianyang, GU Weili. Reducing the fatality rate of acute pancreatitis：A discussion based on the 2021 Edition of the Japanese Guidelines for Acute Pancreatitis[J]. Guangzhou Medical Journal, 2024, 55(1): 9-17.

参考文献

[1] BRIZI M G,PERILLO F,CANNONE F,et al.The role of imaging in acute pancreatitis[J].Radiol Med,2021,126(8):1017-1029.
[2] GREENBERG J A,HSU J,BAWAZEER M,et al.Clinical practice guideline:management of acute pancreatitis[J].Can J Surg,2016,59(2):128-140.
[3] 日本腹部救急医学会,日本肝胆膵外科学会,日本膵臓学会,等.急性膵炎診療ガイドライン2021[M].Japan:金原出版株式会社,2021.
[4] MASAMUNE A,KIKUTA K,HAMADA S,et al.Clinical practice of acute pancreatitis in Japan:An analysis of nationwide epidemiological survey in 2016[J].Pancreatology,2020,20(4):629-636.
[5] BANKS P A,BOLLEN T L,DERVENIS C,et al.Classification of acute pancreatitis-2012:revision of the Atlanta classification and definitions by international consensus[J].Gut,2013,62(1):102-111.
[6] LANKISCH P G,APTE M,BANKS P A.Acute pancreatitis[J].Lancet,2015,386(9988):85-96.
[7] BALTHAZAR E J,RANSON J H,NAIDICH D P,et al.Acute pancreatitis:prognostic value of CT[J].Radiology,1985,156(3):767-772.
[8] LONDON N J,NEOPTOLEMOS J P,LAVELLE J,et al.Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis:A prospective study[J].Br J Surg,1989,76(3):268-272.
[9] KING N K,POWELL J J,REDHEAD D,et al.A simplified method for computed tomographic estimation of prognosis in acute pancreatitis[J].Scand J Gastroenterol,2003,38(4):433-436.
[10] SCHRÖDER T,KIVISAARI L,SOMER K,et al.Significance of extrapancreatic findings in computed tomography(CT)of acute pancreatitis[J].Eur J Radiol,1985,5(4):273-275.
[11] DE WAELE J J,DELRUE L,HOSTE E A,et al.Extrapancreatic inflammation on abdominal computed tomography as an early predictor of disease severity in acute pancreatitis:evaluation of a new scoring system[J].Pancreas,2007,34(2):185-190.
[12] MORTELÉ K J,MERGO P J,TAYLOR H M,et al.Peripancreatic vascular abnormalities complicating acute pancreatitis:contrast-enhanced helical CT findings[J].Eur J Radiol,2004,52(1):67-72.
[13] BALTHAZAR E J.Acute pancreatitis:assessment of severity with clinical and CT evaluation[J].Radiology,2002,223(3):603-613.
[14] 王国兴,肖红丽,任恩峰.急性胰腺炎急诊诊断及治疗专家共识[J].临床肝胆病杂志,2021,37(5):1034-1041.
[15] BARON T H,DIMAIO C J,WANG A Y,et al.American gastroenterological association clinical practice update:Management of pancreatic necrosis[J].Gastroenterology,2020,158(1):67-75.e1.
[16] JABER S,GARNIER M,ASEHNOUNE K,et al.Guidelines for the management of patients with severe acute pancreatitis,2021[J].Anaesth Crit Care Pain Med,2022,41(3):101060.
[17] GLIEM N,AMMER-HERRMENAU C,ELLENRIEDER V,et al.Management of severe acute pancreatitis:An update[J].Digestion,2021,102(4):503-507.
[18] POPOV A,ERSHOVA A,PODTAEV S,et al.Early differential diagnosis of the severity of acute pancreatitis[J].J Clin Monit Comput,2017,31(6):1289-1297.
[19] TAYDAS O,UNAL E,KARAOSMANOGLU A D,et al.Accuracy of early CT findings for predicting disease course in patients with acute pancreatitis[J].Jpn J Radiol,2018,36(2):151-158.
[20] ROBERTS S E,MORRISON-REES S,JOHN A,et al.The incidence and aetiology of acute pancreatitis across Europe[J].Pancreatology,2017,17(2):155-165.
[21] BOXHOORN L,VOERMANS R P,BOUWENSE S A,et al.Acute pancreatitis[J].Lancet,2020,396(10252):726-734.
[22] LIU C L,LO C M,CHAN J K,et al.Detection of choledocholithiasis by EUS in acute pancreatitis:A prospective evaluation in 100 consecutive patients[J].Gastrointest Endosc,2001,54(3):325-330.
[23] LIU C L,FAN S T,LO C M,et al.Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis:A prospective randomized study[J].Clin Gastroenterol Hepatol,2005,3(12):1238-1244.
[24] 曹锋,李非,赵玉沛.中国急性胰腺炎诊治指南(2021)[J].中国实用外科杂志,2021,41(7):758-761.
[25] HANKEY G J.Stroke[J].Lancet,2017,389(10069):641-654.
[26] 中国老年医学学会急诊医学分会,中华医学会急诊医学分会卒中学组,中国卒中学会急救医学分会.急性缺血性脑卒中急诊急救中国专家共识2018版(上)[J].心脑血管病防治,2019,19(3):201-204.
[27] HARRIS D,HALL C,LOBAY K,et al.Canadian association of emergency physicians position statement on acute ischemic stroke[J].CJEM,2015,17(2):217-226.
[28] 颜红兵,向定成,刘红梅,等.ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识[J].中国实用内科杂志,2018,38(5):434-442.
[29] PETROV M S,SHANBHAG S,CHAKRABORTY M,et al.Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis[J].Gastroenterology,2010,139(3):813-820.
[30] HORIBE M,NISHIZAWA T,SUZUKI H,et al.Timing of oral refeeding in acute pancreatitis:A systematic review and meta-analysis[J].United European Gastroenterol J,2016,4(6):725-732.
[31] FALCH C,VICENTE D,HÄBERLE H,et al.Treatment of acute abdominal pain in the emergency room:a systematic review of the literature[J].Eur J Pain,2014,18(7):902-913.
[32] DONG E,CHANG J I,VERMA D,et al.Enhanced recovery in mild acute pancreatitis:A Randomized Controlled Trial[J].Pancreas,2019,48(2):176-181.
[33] GÜLEN B,DUR A,SERINKEN M,et al.Pain treatment in patients with acute pancreatitis:A randomized controlled trial[J].Turk J Gastroenterol,2016,27(2):192-196.
[34] LEPPÄNIEMI A,TOLONEN M,TARASCONI A,et al.2019 WSES guidelines for the management of severe acute pancreatitis[J].World J Emerg Surg,2019(14):27.
[35] VIVIAN E,CLER L,CONWELL D,et al.Acute pancreatitis task force on quality:development of quality indicators for acute pancreatitis management[J].Am J Gastroenterol,2019,114(8):1322-1342.
[36] CROCKETT S D,WANI S,GARDNER T B,et al.American gastroenterological association institute guideline on Initial management of acute pancreatitis[J].Gastroenterology,2018,154(4):1096-1101.
[37] SINGH V K,GARDNER T B,PAPACHRISTOU G I,et al.An international multicenter study of early intravenous fluid administration and outcome in acute pancreatitis[J].United European Gastroenterol J,2017,5(4):491-498.
[38] DU X J,HU W M,XIA Q,et al.Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis[J].Pancreas,2011,40(8):1220-1225.
[39] ZHAO G,ZHANG J G,WU H S,et al.Effects of different resuscitation fluid on severe acute pancreatitis[J].World J Gastroenterol,2013,19(13):2044-2052.
[40] WU B U,HWANG J Q,GARDNER T H,et al.Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis[J].Clin Gastroenterol Hepatol,2011,9(8):710-717.e1.
[41] IQBAL U,ANWAR H,SCRIBANI M.Ringer’s lactate versus normal saline in acute pancreatitis:A systematic review and meta-analysis[J].J Dig Dis,2018,19(6):335-341.
[42] LIPINSKI M,RYDZEWSKA-ROSOLOWSKA A,RYDZEWSKI A,et al.Fluid resuscitation in acute pancreatitis:Normal saline or lactated Ringer’s solution?[J].World J Gastroenterol,2015,21(31):9367-9372.
[43] BAI Y,GAO J,ZOU D W,et al.Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis:evidence from a meta-analysis of randomized controlled trials[J].Am J Gastroenterol,2008,103(1):104-110.
[44] SZATMARY P,GRAMMATIKOPOULOS T,CAI W,et al.Acute pancreatitis:diagnosis and treatment[J].Drugs,2022,82(12):1251-1276.
[45] GUO D,DAI W,SHEN J,et al.Assessment of prophylactic carbapenem antibiotics administration for severe acute pancreatitis:An updated systematic review and meta-analysis[J].Digestion,2022,103(3):183-191.
[46] SIRIWARDENA A K,JEGATHEESWARAN S,MASON J M.A procalcitonin-based algorithm to guide antibiotic use in patients with acute pancreatitis(PROCAP):a single-centre,patient-blinded,randomised controlled trial[J].Lancet Gastroenterol Hepatol,2022,7(10):913-921.
[47] KALAS M A,LEON M,CHAVEZ L O,et al.Vascular complications of pancreatitis[J].World J Clin Cases,2022,10(22):7665-7673.
[48] GARDNER T B.Acute Pancreatitis[J].Ann Intern Med,2021,174(2):Itc17-itc32.
[49] JIANG Z Q,XIAO B,ZHANG X M,et al.Early-phase vascular involvement is associated with acute pancreatitis severity:A magnetic resonance imaging study[J].Quant Imaging Med Surg,2021,11(5):1909-1920.
[50] BESSELINK M G.Splanchnic vein thrombosis complicating severe acute pancreatitis[J].HPB(Oxford),2011,13(12):831-832.
[51] NAWACKI Ł,MATYKIEWICZ J,STOCHMAL E,et al.Splanchnic vein thrombosis in acute pancreatitis and its consequences[J].Clin Appl Thromb Hemost,2021(27):10760296211010260.
[52] GONZELEZ H J,SAHAY S J,SAMADI B,et al.Splanchnic vein thrombosis in severe acute pancreatitis:a 2-year,single-institution experience[J].HPB(Oxford),2011,13(12):860-864.
[53] CHANDAN S,BUDDAM A,KHAN S R,et al.Use of therapeutic anticoagulation in splanchnic vein thrombosis associated with acute pancreatitis:a systematic review and meta-analysis[J].Ann Gastroenterol,2021,34(6):862-871.
[54] ZHOU J,ZHANG H,MAO W,et al.Efficacy and safety of early systemic anticoagulation for preventing splanchnic thrombosis in acute necrotizing pancreatitis[J].Pancreas,2020,49(9):1220-1224.
[55] SISSINGH N J,GROEN J V,KOOLE D,et al.Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis:A systematic review and meta-analysis[J].Pancreatology,2022,22(2):235-243.
[56] HIROTA M,MAYUMI T,SHIMOSEGAWA T.Acute pancreatitis bundles:10 clinical regulations for the early management of patients with severe acute pancreatitis in Japan[J].J Hepatobiliary Pancreat Sci,2014,21(11):829-830.

降低急性胰腺炎的病死率：基于日本2021版诊疗指南的探讨

Reducing the fatality rate of acute pancreatitis：A discussion based on the 2021 Edition of the Japanese Guidelines for Acute Pancreatitis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价

[1]	李东方. 心房颤动患者住院病死率的影响因素单中心研究[J]. 广州医药, 2023, 54(9): 98-102.
[2]	陈杰舜, 廖银光. CRRT在治疗重症急性胰腺炎中的应用[J]. 广州医药, 2022, 53(5): 101-104.
[3]	田丹. 罗格列酮联合乌司他丁治疗急性胰腺炎患者的临床研究[J]. 广州医药, 2021, 52(6): 126-129.
[4]	陈希妍, 张建新, 孔令宇, 牛丽丹, 李广鹏, 朱秀英, 石金河. 大鼠急性胰腺炎外分泌细胞自噬中miR-148a的作用研究[J]. 广州医药, 2021, 52(4): 1-4.
[5]	彭慧芸, 袁瑜, 谢文瑞, 吴礼浩. 早期经鼻肠内营养对中-重度急性胰腺炎患者的疗效观察[J]. 广州医药, 2020, 51(2): 77-80.
[6]	欧娅, 黄耀星, 苏伟, 罗键雄, 陈伟明, 唐翔, 陈泳华, 张婷婷. 血必净注射液对SAP大鼠TLR4信号通路介导肠黏膜屏障功能障碍的影响[J]. 广州医药, 2019, 50(3): 1-5.
[7]	陈静. 血必净联合乌司他丁治疗重症急性胰腺炎的疗效及对血清细胞因子水平的影响[J]. 广州医药, 2018, 49(3): 71-72.
[8]	李文礼, 张海星, 刘伟斌, 谢亨银. 13例重症急性胰腺炎诊治特点临床分析[J]. 广州医药, 2016, 47(5): 54-56.
[9]	刘丽英. 鼻—空肠营养管在小儿急性胰腺炎中的疗效观察及护理[J]. 广州医药, 2016, 47(1): 55-56.
[10]	冯健华. 血清降钙素原与中性粒细胞淋巴细胞比率对急性胰腺炎继发急性肺损伤的预测价值[J]. 广州医药, 2015, 46(3): 60-63.